BackPhoenix Biotech Acquisition Overview
Phoenix Biotech Acquisition Corp - Class A

Phoenix Biotech Acquisition PEG Ratio

Phoenix Biotech Acquisition (PBAX) has a PEG ratio of 12.4, above the sector sector average of 9.98.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

12.40

PEG Ratio

12.40

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Phoenix Biotech Acquisition (PBAX) FAQ

The latest PEG ratio for PBAX is 12.4. That is above the sector sector average of 9.98. Investors often review this figure alongside Phoenix Biotech Acquisition's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, PBAX currently prints 12.4 for PEG ratio, while the sector average sits near 9.98. That is roughly 24.2% above the sector mean. Large gaps often invite a closer look at Phoenix Biotech Acquisition's growth, margins, and balance sheet.

A PEG ratio of 12.4 for Phoenix Biotech Acquisition is not 'good' or 'bad' on its own. Compare it with the peer average (9.98) and with PBAX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting PBAX's PEG ratio (12.4), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.